International Journal of Tuberculosis and Lung Disease

Article	Citations
The impact of COVID-19 on TB: a review of the data	121
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries	79
Post-tuberculosis lung health: perspectives from the First International Symposium	76
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19	67
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis	45
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	45
New diseases and old threats: lessons from tuberculosis for the COVID-19 response	37
COVID-19 and tuberculosis—threats and opportunities	36
Impact of COVID-19 on tuberculosis control in China	32
Impact of COVID-19 on TB diagnosis in Northeastern Brazil	32
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria	29
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China	29
Mask wearing to complement social distancing and save lives during COVID-19	28
Air pollution interventions and respiratory health: a systematic review	26
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda	24
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review	23
The impact of smoking on tuberculosis treatment outcomes: a meta-analysis	23
Post-tuberculosis sequelae: the need to look beyond treatment outcome	22
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa	22
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	22
Tobacco control in China and the road to Healthy China 2030	21
Should we consider a ‘fourth 90’ for tuberculosis?	20
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	20
Severe COVID-19 cases with a history of active or latent tuberculosis	19
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	19

A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic	19
Clinical standards for the diagnosis, treatment and prevention of TB infection	19
How TB and COVID-19 compare: an opportunity to integrate both control programmes	18
Impact of COVID-19 on tuberculosis services in India	18
Occupational asthma	18
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis	18
The need for pulmonary rehabilitation following tuberculosis treatment	18
Impact of the global COVID-19 outbreak on the management of other communicable diseases	18
The Global Asthma Report 2022	18
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial	17
Thrombotic events and COVID-19 vaccines	17
Critical changes to services for TB patients during the COVID-19 pandemic	17
TB and COVID-19 co-infection: rationale and aims of a global study	17
The COVID-19 and TB syndemic: the way forward	17
Adapting TB services during the COVID-19 pandemic in Mumbai, India	17
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid	16
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	16
Resource reprioritisation amid competing health risks for TB and COVID-19	15
Asbestos-related diseases	15
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	15
Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis	14
Clinical standards for the dosing and management of TB drugs	13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries	13
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa	13
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic	13
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	13
Comparative analysis of Truenat™ MTB Plus and Xpert® Ultra in diagnosing tuberculous meningitis	13
TB and the COVID-19 pandemic: brothers in arms against lung health	13
Mortality due to TB-COVID-19 coinfection in India	13
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine	12
National population-based tuberculosis prevalence survey in Ghana, 2013	12
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment	12
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?	12
The burden and determinants of post-TB lung disease	12
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest	12
Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort	12
A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence	12
How to demystify COVID-19 and reduce social stigma	12
Bedaquiline for multidrug-resistant TB in paediatric patients	11
Delays and barriers to early treatment initiation for childhood tuberculosis in India	11
TB multimorbidity: a global health challenge demanding urgent attention	11
WHO drug-resistant TB guidelines 2022: what is new?	11
Automated chest radiography and mass systematic screening for tuberculosis	11
Let us not forget the mask in our attempts to stall the spread of COVID-19	11
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning	11
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms	11
Person-centred care in TB	11
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis	10
Policies, practices and barriers to implementing tuberculosis preventive treatment—35 countries, 2017	10
Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–2014	10

Sustaining essential healthcare in Africa during the COVID-19 pandemic	10
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini	10
The impact of COVID-19 on the diagnosis of TB in Taiwan	10
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis	10
Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy	9
Patient-cost survey for tuberculosis in the context of patient-pathway modelling	9
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression	9
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review	9
Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar	9
Geographic distribution, socio-economic disparity and policy determinants of smoke-free policy adoption in Indonesia	9
Anthropogenic climate change and health in the Global South	9
Predictive models for COVID-19-related deaths and infections	9
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose	9
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa	9
A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes	9
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment	9
Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs	9
How to manage children if a second wave of COVID-19 occurs	9
The fourth national anti-tuberculosis drug resistance survey in Peru	9
Risk factors for chronic pulmonary aspergillosis in post-TB patients	9
First-line tuberculosis treatment with double-dose rifampicin is well tolerated	8
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	8
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB	8
Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis	8
A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis	8
Breastfeeding in women living with tuberculosis	8
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey	8
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives	8
Post-TB health and wellbeing	8
COPD exacerbation rates are higher in non-smoker patients in India	8
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	8
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India	8
First molecular-based anti-TB drug resistance survey in Eritrea	8
Real-world implementation of video-observed therapy in an urban TB program in the United States	8
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium	8
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis	8
Preparing national tuberculosis control programmes for COVID-19	8
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia	8
Performance of a household tuberculosis exposure survey among children in a Latin American setting	8
Priorities among HIV-positive individuals for tuberculosis preventive therapies	8
The impact of PM2.5 on lung function in adults with asthma	8
Determining the value of TB active case-finding: current evidence and methodological considerations	8
Chronic obstructive pulmonary disease in sub-Saharan Africa	7
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths	7
Spatial variability in the risk of death from COVID-19 in Italy	7
Determinants of lung health across the life course in sub-Saharan Africa	7
Minimal clinically important difference of the 6-min walking test in patients with asthma	7
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis	7
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?	7
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis	7
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV	7
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study	7
Multidrug-resistant tuberculosis in the United States, 2011–2016: patient characteristics and risk factors	7
Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste	7
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia	7
Cost of TB services in healthcare facilities in Kenya (No 3)	7
Tuberculosis patients with higher levels of poverty face equal or greater costs of illness	7
Modelling the potential impact of adherence technologies on tuberculosis in India	7
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing	7
Number needed to screen for TB in clinical, structural or occupational risk groups	7
The catastrophic cost of tuberculosis: advancing research and solutions	7
Respiratory health among office workers in Malaysia and endotoxin and (1,3)-β-glucan in office dust	6
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa	6
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	6
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain	6
Vitamin D deficiency is associated with tuberculosis disease in British children	6
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries	6
Opportunities to improve digital adherence technologies and TB care using human-centered design	6
Impact of COVID-19 on patients with asthma	6
TB and TB-HIV care for adolescents and young adults	6
The scientific response to TB – the other deadly global health emergency	6
Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field	6
An Inca trail to the Holy Grail: digital medication adherence support for TB care	6
Costs of TB services in India (No 1)	6
High yields from contact investigation of child index TB patients	6
Cost savings associated with video directly observed therapy for treatment of tuberculosis	6
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men	6
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	6
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia	6
Cost of TB services in the public and private sectors in Georgia (No 2)	5

Continuity of TB services during the COVID-19 pandemic in China	5
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort	5
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	5
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	5
Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi	5
QT prolongation in the STREAM Stage 1 Trial	5
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed	5
Face masks – a sustainable measure to mitigate COVID-19	5
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	5
COVID-19: ensuring continuity of TB services in the private sector	5
The diagnosis of lung cancer in the era of interventional pulmonology	5
Concern over a COVID-19-related BCG shortage	5
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	5
Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis	5
Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis	5
Key changes in the public health response to TB and HIV in South Africa	5
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	5
Characteristics of a “rebound” in smoking after a tobacco price increase	5
The effect of systematic screening of the general population on TB case notification rates	5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB	5
Tuberculosis trends in a hot-spot region in Paris, France	5
Rapid development of a portable negative pressure procedural tent	5
Xpert® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates	5
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB	5
Towards quality adolescent-friendly services in TB care	5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	5
A systematic review of the number needed to screen for active TB among people living with HIV	5
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study	5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes	5
Setting up pharmacovigilance based on available endTB Project data for bedaquiline	5
Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil	4
Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results	4
UNITE4TB: a new consortium for clinical drug and regimen development for TB	4
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa	4
Seasonality, climate change and tuberculosis: new data and old lessons	4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation	4
The war in Ukraine and potential consequences for the TB epidemic in Europe	4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients	4
COVID-19 and TB control in immigrant communities	4
Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis	4
The impact of COVID-19 on the TB response: data from the field	4
VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB	4
Effects of comorbidities on quality of life in Filipino people with tuberculosis	4
Helping Africa to breathe when COVID-19 strikes	4
Adipokines and the risk of active TB: a nested case-control study	4
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility	4
Decreased notification of TB cases during the COVID-19 pandemic	4
Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays	4
Preventive treatment of drug-resistant TB in a rural setting	4
Density of cigarette retailers around educational facilities in Indonesia	4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free	4
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy	4
Completion of treatment for latent TB infection in a low prevalence setting	4
Chronic kidney disease, tuberculosis and climate change	4
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town	4
Density of tobacco advertising around schools	4
COVID-19 in Africa: community and digital technologies for tuberculosis management	4
The Asthma Drug Facility and the future management of asthma	4
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City	4
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data	4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes	4
TB in older people in Asia: why it is important	4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients	4
Clinical standards for drug-susceptible pulmonary TB	4
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam	4
Impact of influenza A co-infection with COVID-19	4
How mechanistic in silico modelling can improve our understanding of TB disease and treatment	4
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes	4
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children	4
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?	4
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–2017	4
Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c	4
Tobacco use and quitting behaviour during COVID-19 lockdown	4
COVID-19 and TB: a progression-regression conundrum	4
A public health approach to increase treatment of latent TB among household contacts in Brazil	4
Knowledge, attitudes and practices on childhood TB among healthcare workers	4
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study	3
Epidemiology of tuberculosis among healthcare personnel in New York City	3
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study	3
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan	3
Increase in disseminated TB during the COVID‐19 pandemic	3
Treatment success, but living with the consequences of post-tuberculosis sequelae	3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines	3
Using a geographic information system as a management tool for tuberculosis control	3
Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015	3
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action	3
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis	3
Introducing new and repurposed TB drugs: the endTB experience	3
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV	3
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	3
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis	3
An assessment of current tuberculosis patient care and support policies in high-burden countries	3
Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?	3
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens	3
Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting	3
TB testing in HIV-positive patients prior to antiretroviral treatment	3
TB in children and adolescents	3
Impact of the COVID-19 pandemic on TB infection testing	3
How much does TB screening cost? A systematic review of economic evaluations	3
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding	3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	3
Treatment outcomes and safety in children with rifampicin-resistant TB	3
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	3
Work-related interstitial lung disease: what is the true burden?	3
Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti	3
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens	3
Psychological distress among TB patients in sub-Saharan Africa	3
Adapting a TB contact investigation strategy for COVID-19	3
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease	3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	3
Planning for TB elimination in Lebanon	3
Risk factors for the delayed diagnosis of extrapulmonary TB	3
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity	3
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB	3
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon	3
Post-TB bronchiectasis: from pathogenesis to rehabilitation	3
Diagnostic code agreement for electronic health records and claims data for tuberculosis	3
Country differences and determinants of yield in programmatic migrant TB screening in four European countries	3
WHO target product profiles for TB preventive treatment	3
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally	3
Impact of COVID-19 on TB services in Korea	3
Screening for active and latent TB among migrants in France	3
Engaging private pharmacies to help end TB in India	3
Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness	3
Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease	3
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis	3
Reference values of impulse oscillometry (IOS) for healthy Indian adults	3
Determinants of treatment outcomes in patients with multidrug-resistant TB	3
Undernutrition can no longer be an afterthought for global efforts to eliminate TB	3
Patterns of suboptimal adherence among adolescents treated for tuberculosis	3
What to look for when using SUBsET for subnational TB incidence estimates	3
Incremental yield of Xpert® MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB	3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali	3
Changes to TB care in an outpatient centre during the COVID‐19 pandemic	3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	3
TB outcomes and mortality risk factors in adult migrants at the Thailand-Myanmar border	3
Impact of lung function on treatment outcome in patients with TB	3
Associations between air pollutants and peak expiratory flow and fractional exhaled nitric oxide in students	3